ClinicalTrials.govpublic full text
A Phase I, Dose-Escalation Study to Assess the Safety and Biological Activity of Recombinant Human Interleukin-18
lymphoma, non-hodgkin, rituximab,, oncology, il-18,, combination study,, cytokine,, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 802388
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.